Boston Scientific Corporation acquired clearance from the U.S. Food and Drug Administration (FDA) for its EMBOLD Fibered Detachable Coil that decreases the rate of peripheral vasculature blood flow.
BIOTRONIK, Inc. received approval of Renamic New, a software programmer for cardiac rhythm management devices, from the U.S. Food and Drug Administration (FDA).
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?